Related Experiment Video

Updated: Aug 23, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

Nrf2-dependent gene expressions: a molecular toxicological aspect

Satoshi Numazawa1, Takemi Yoshida

  • 1Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555, Japan.

The Journal of Toxicological Sciences
|June 23, 2004
PubMed

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a master regulator of antioxidant and detoxification genes. Its function depends on nuclear localization, controlled by Keap1 interaction and turnover, impacting physiological and toxicological processes.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Toxicology

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) initially identified for beta-globin gene regulation.
  • Nrf2 is now recognized as a master regulator of antioxidant and detoxification pathways.
  • Nrf2 activity is tightly controlled by its nuclear localization and protein stability.

Purpose of the Study:

  • To review the regulatory mechanisms governing Nrf2 function.
  • To discuss the physiological roles of Nrf2.
  • To explore the toxicological implications of Nrf2 activity.

Main Methods:

  • Literature review of Nrf2 regulation.
  • Analysis of Nrf2's interaction with Keap1.
  • Discussion of Nrf2's role in cellular stress responses.

Main Results:

  • Nrf2's transcriptional activity is contingent on its presence in the nucleus.
  • The Keap1-Nrf2 interaction is a key determinant of Nrf2 stability and localization.
  • Nrf2 orchestrates a broad defense against oxidative stress and electrophilic damage.

Conclusions:

  • Nrf2 is a critical transcription factor for cellular defense mechanisms.
  • Understanding Nrf2 regulation is vital for both physiological health and toxicology.
  • Further research into Nrf2 pathways can reveal therapeutic targets.

More Related Videos

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors09:33

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors

Published on: February 7, 2018

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...